APA (7th ed.) Citation

L, V., R, W., R, M., B, G., E, S., SV, G., . . . MA, S. (2026). Engineered monoclonal antibody tobevibart enhances HBsAg capture by Fc receptor-positive cells and activates HBV-specific T cells. Journal of hepatology, 84(1), 62. https://doi.org/10.1016/j.jhep.2025.08.016

Chicago Style (17th ed.) Citation

L, Vincenzetti, et al. "Engineered Monoclonal Antibody Tobevibart Enhances HBsAg Capture by Fc Receptor-positive Cells and Activates HBV-specific T Cells." Journal of Hepatology 84, no. 1 (2026): 62. https://doi.org/10.1016/j.jhep.2025.08.016.

MLA (9th ed.) Citation

L, Vincenzetti, et al. "Engineered Monoclonal Antibody Tobevibart Enhances HBsAg Capture by Fc Receptor-positive Cells and Activates HBV-specific T Cells." Journal of Hepatology, vol. 84, no. 1, 2026, p. 62, https://doi.org/10.1016/j.jhep.2025.08.016.